{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:23:45Z","timestamp":1777710225958,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/leu.2015.126","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T06:59:21Z","timestamp":1432796361000},"page":"2086-2097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98\u2013HOXA9-induced myeloid disease"],"prefix":"10.1038","volume":"29","author":[{"given":"A P","family":"Deveau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Forrester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G S","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Grabher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I C","family":"Chute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"L\u00e9ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mingay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Alexe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Liwski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Stegmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A T","family":"Look","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J N","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"key":"BFleu2015126_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","volume":"29","author":"A Burnett","year":"2011","unstructured":"Burnett A, Wetzler M, L\u00f6wenberg B . Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011; 29: 487\u2013494.","journal-title":"J Clin Oncol"},{"key":"BFleu2015126_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0305-7372(03)00142-7","volume":"30","author":"A Redaelli","year":"2004","unstructured":"Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL . Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 2004; 30: 103\u2013117.","journal-title":"Cancer Treat Rev"},{"key":"BFleu2015126_CR3","first-page":"257","volume-title":"Acute Myelogenous Leukemia: Genetics, Biology and Therapy","author":"G Borthakur","year":"2010","unstructured":"Borthakur G, Estey EE . Therapy of acute myelogenous leukemia in adults. Nagarajan L. Acute Myelogenous Leukemia: Genetics, Biology and Therapy. Springer New York: New York City, NY, USA, 2010 pp 257\u2013270."},{"key":"BFleu2015126_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1535-6108(02)00081-8","volume":"1","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG, Tallman MS . Focus on acute leukemias. Cancer Cell 2002; 1: 417\u2013420.","journal-title":"Cancer Cell"},{"key":"BFleu2015126_CR5","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","volume":"26","author":"B Argiropoulos","year":"2007","unstructured":"Argiropoulos B, Humphries RK . Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007; 26: 6766\u20136776.","journal-title":"Oncogene"},{"key":"BFleu2015126_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ng0296-159","volume":"12","author":"J Borrow","year":"1996","unstructured":"Borrow J, Shearman AA, Stanton VP, Becher R, Collins T, Williams AJ et al. The t(7;11)(p15;p15) translocation in acute myeloid leukmaemia fuses the genes for nucleoporin NUP98 and class 1 homeoprotein HOXA9. Nat Genet 1996; 12: 159\u2013167.","journal-title":"Nat Genet"},{"key":"BFleu2015126_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/sj.leu.2401578","volume":"13","author":"HJ Lawrence","year":"1999","unstructured":"Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, K\u00f6m\u00fcves L et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 1999; 13: 1993\u20131999.","journal-title":"Leukemia"},{"key":"BFleu2015126_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP . Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531\u2013537.","journal-title":"Science"},{"issue":"1","key":"BFleu2015126_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/asheducation-2002.1.73","volume":"2002","author":"F. J. Giles","year":"2002","unstructured":"Giles FJ, Keating A, Goldstone AH, Avivi I, Willman CL, Kantarjian HM . Acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2002, 73\u2013110.","journal-title":"Hematology"},{"key":"BFleu2015126_CR10","doi-asserted-by":"publisher","first-page":"13120","DOI":"10.1073\/pnas.231115398","volume":"98","author":"KR Calvo","year":"2001","unstructured":"Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP . Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci USA 2001; 98: 13120\u201313125.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015126_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","volume":"113","author":"J Faber","year":"2009","unstructured":"Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009; 113: 2375\u20132385.","journal-title":"Blood"},{"key":"BFleu2015126_CR12","doi-asserted-by":"publisher","first-page":"e53161","DOI":"10.1371\/journal.pone.0053161","volume":"8","author":"Y Ohno","year":"2013","unstructured":"Ohno Y, Yasunaga S, Janmohamed S, Ohtsubo M, Saeki K, Kurogi T et al. Hoxa9 transduction induces hematopoietic stem and progenitor cell activity through direct down-regulation of geminin protein. PLoS One 2013; 8: e53161.","journal-title":"PLoS One"},{"key":"BFleu2015126_CR13","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1038\/sj.onc.1205516","volume":"21","author":"KR Calvo","year":"2002","unstructured":"Calvo KR, Sykes DB, Pasillas MP, Kamps MP . Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene 2002; 21: 4247\u20134256.","journal-title":"Oncogene"},{"key":"BFleu2015126_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2141.1999.01754.x","volume":"107","author":"Y Hatano","year":"1999","unstructured":"Hatano Y, Miura I, Nakamura T, Yamazaki Y, Takahashi N, Miura AB . Molecular heterogeneity of the NUP98\/HOXA9 fusion transcript in myelodysplastic syndromes associated with t(7;11)(p15;p15). Br J Haematol 1999; 107: 600\u2013604.","journal-title":"Br J Haematol"},{"key":"BFleu2015126_CR15","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","volume":"17","author":"E Kroon","year":"1998","unstructured":"Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G . Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714\u20133725.","journal-title":"EMBO J"},{"key":"BFleu2015126_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/emboj\/20.3.350","volume":"20","author":"E Kroon","year":"2001","unstructured":"Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G . NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 2001; 20: 350\u2013361.","journal-title":"EMBO J"},{"key":"BFleu2015126_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1126\/science.1080280","volume":"299","author":"DM Langenau","year":"2003","unstructured":"Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003; 299: 887\u2013890.","journal-title":"Science"},{"key":"BFleu2015126_CR18","doi-asserted-by":"publisher","first-page":"15166","DOI":"10.1073\/pnas.0603349103","volume":"103","author":"HE Sabaawy","year":"2006","unstructured":"Sabaawy HE, Azuma M, Embree LJ, Tsai H-J, Starost MF, Hickstein DD . TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006; 103: 15166\u201315171.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015126_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/291293a0","volume":"291","author":"G Streisinger","year":"1981","unstructured":"Streisinger G, Walker C, Dower N, Knauber D, Singer F . Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 1981; 291: 293\u2013296.","journal-title":"Nature"},{"key":"BFleu2015126_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nchembio.147","volume":"5","author":"J-RJ Yeh","year":"2009","unstructured":"Yeh J-RJ, Munson KM, Elagib KE, Goldfarb AN, Sweetser DA, Peterson RT . Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat Chem Biol 2009; 5: 236\u2013243.","journal-title":"Nat Chem Biol"},{"key":"BFleu2015126_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2141.2011.08810.x","volume":"155","author":"AM Forrester","year":"2011","unstructured":"Forrester AM, Grabher C, McBride ER, Boyd ER, Vigerstad MH, Edgar A et al. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis. Br J Haematol 2011; 155: 167\u2013181.","journal-title":"Br J Haematol"},{"key":"BFleu2015126_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/nature05883","volume":"447","author":"TE North","year":"2007","unstructured":"North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447: 1007\u20131011.","journal-title":"Nature"},{"key":"BFleu2015126_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","volume":"8","author":"W Goessling","year":"2011","unstructured":"Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011; 8: 445\u2013458.","journal-title":"Cell Stem Cell"},{"key":"BFleu2015126_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z et al. The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010; 327: 1650\u20131653.","journal-title":"Science"},{"key":"BFleu2015126_CR25","volume-title":"The zebrafish book. A Guide For The Laboratory Use of Zebrafish (Danio rerio)","author":"M Westerfield","year":"2000","unstructured":"Westerfield M . The zebrafish book. A Guide For The Laboratory Use of Zebrafish (Danio rerio). 4th edn University of Oregon Press: Eugene, Oregon, 2000."},{"key":"BFleu2015126_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature08761","volume":"464","author":"K Kissa","year":"2010","unstructured":"Kissa K, Herbomel P . Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464: 112\u2013115.","journal-title":"Nature"},{"key":"BFleu2015126_CR27","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1182\/blood-2005-01-0179","volume":"106","author":"H-F Lin","year":"2005","unstructured":"Lin H-F, Traver D, Zhu H, Dooley K, Paw BH, Zon LI et al. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood 2005; 106: 3803\u20133810.","journal-title":"Blood"},{"key":"BFleu2015126_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1182\/blood-2008-04-149898","volume":"113","author":"EYN Lam","year":"2009","unstructured":"Lam EYN, Chau JYM, Kalev-Zylinska ML, Fountaine TM, Mead RS, Hall CJ et al. Zebrafish runx1 promoter-EGFP transgenics mark discrete sites of definitive blood progenitors. Blood 2009; 113: 1241\u20131249.","journal-title":"Blood"},{"key":"BFleu2015126_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1182\/blood.V98.3.643","volume":"98","author":"CM Bennett","year":"2001","unstructured":"Bennett CM, Kanki JP, Rhodes J, Liu TX, Paw BH, Kieran MW et al. Myelopoiesis in the zebrafish, Danio rerio. Blood 2001; 98: 643\u2013651.","journal-title":"Blood"},{"key":"BFleu2015126_CR30","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","volume":"113","author":"BJ Wouters","year":"2009","unstructured":"Wouters BJ, L\u00f6wenberg B, Erpelinck-Verschueren CaJ, Van Putten WLJ, Valk PJM, Delwel R . Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 2009; 113: 3088\u20133091.","journal-title":"Blood"},{"key":"BFleu2015126_CR31","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Network TCGAR","year":"2013","unstructured":"Network TCGAR. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia The Cancer Genome Atlas Research Network. N Engl J Med 2013; 368: 2059\u20132074.","journal-title":"N Engl J Med"},{"key":"BFleu2015126_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1128\/MCB.21.1.224-234.2001","volume":"21","author":"U Thorsteinsdottir","year":"2001","unstructured":"Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G . Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia. Mol Cell Biol 2001; 21: 224\u2013234.","journal-title":"Mol Cell Biol"},{"key":"BFleu2015126_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3324\/haematol.2010.027698","volume":"96","author":"A Cvejic","year":"2011","unstructured":"Cvejic A, Serbanovic-Canic J, Stemple DL, Ouwehand WH . The role of meis1 in primitive and definitive hematopoiesis during zebrafish development. Haematologica 2011; 96: 190\u2013198.","journal-title":"Haematologica"},{"key":"BFleu2015126_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.008904","volume":"135","author":"J-RJ Yeh","year":"2008","unstructured":"Yeh J-RJ, Munson KM, Chao YL, Peterson QP, Macrae CA, Peterson RT . AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 2008; 135: 401\u2013410.","journal-title":"Development"},{"key":"BFleu2015126_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.seminoncol.2011.11.011","volume":"39","author":"Y Saunthararajah","year":"2012","unstructured":"Saunthararajah Y, Triozzi P, Rini B, Singh A, Radivoyevitch T, Sekeres M et al. P53-independent, normal stem cell sparing epigenetic-differentation therapy for myeloid and other malignancies. Semin Oncol 2012; 39: 97\u2013108.","journal-title":"Semin Oncol"},{"key":"BFleu2015126_CR36","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1200\/JCO.2011.35.4894","volume":"29","author":"F Thol","year":"2011","unstructured":"Thol F, Damm F, L\u00fcdeking A, Winschel C, Wagner K, Morgan M et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 2011; 29: 2889\u20132896.","journal-title":"J Clin Oncol"},{"key":"BFleu2015126_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1101\/gad.184341.111","volume":"26","author":"JJ Trowbridge","year":"2012","unstructured":"Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH . Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes Dev 2012; 26: 344\u2013349.","journal-title":"Genes Dev"},{"key":"BFleu2015126_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ydbio.2010.11.009","volume":"350","author":"RK Tittle","year":"2011","unstructured":"Tittle RK, Sze R, Ng A, Nuckels RJ, Swartz ME, Anderson RM et al. Uhrf1 and Dnmt1 are required for development and maintenance of the zebrafish lens. Dev Biol 2011; 350: 50\u201363.","journal-title":"Dev Biol"},{"key":"BFleu2015126_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1091\/mbc.e11-06-0487","volume":"23","author":"J Chu","year":"2011","unstructured":"Chu J, Loughlin Ea, Gaur Na, SenBanerjee S, Jacob V, Monson C et al. UHRF1 phosphorylation by cyclin A2\/cyclin-dependent kinase 2 is required for zebrafish embryogenesis. Mol Biol Cell 2011; 23: 59\u201370.","journal-title":"Mol Biol Cell"},{"key":"BFleu2015126_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature07249","volume":"455","author":"K Arita","year":"2008","unstructured":"Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M . Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism.pdf. Nature 2008; 455: 818\u2013821.","journal-title":"Nature"},{"key":"BFleu2015126_CR41","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1147939","volume":"317","author":"M Bostick","year":"2007","unstructured":"Bostick M, Kim JK, Est\u00e8ve PO, Clark A, Pradhan S, Jacobsen SE . UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317: 1760\u20131764.","journal-title":"Science"},{"key":"BFleu2015126_CR42","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cbic.201100130","volume":"12","author":"A Ceccaldi","year":"2011","unstructured":"Ceccaldi A, Rajavelu A, Champion C, Rampon C, Jurkowska R, Jankevicius G et al. C5-DNA Methyltransferase Inhibitors: From Screening to Effects on Zebrafish Embryo Development. ChemBioChem 2011; 12: 1337\u20131345.","journal-title":"ChemBioChem"},{"key":"BFleu2015126_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","volume":"30","author":"A Guidotti","year":"2009","unstructured":"Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E . Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 2009; 30: 55\u201360.","journal-title":"Trends Pharmacol Sci"},{"key":"BFleu2015126_CR44","first-page":"629","volume":"31","author":"F Bellos","year":"2008","unstructured":"Bellos F, Mahlknecht U . Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients. Onkologie 2008; 31: 629\u2013633.","journal-title":"Onkologie"},{"key":"BFleu2015126_CR45","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001; 20: 6969\u20136978.","journal-title":"EMBO J"},{"key":"BFleu2015126_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35106079","volume":"1","author":"P Marks","year":"2001","unstructured":"Marks P, Rifkind Ra, Richon VM, Breslow R, Miller T, Kelly WK . Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001; 1: 194\u2013202.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2015126_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/71750","volume":"24","author":"F Fuks","year":"2000","unstructured":"Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T . DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 2000; 24: 88\u201391.","journal-title":"Nat Genet"},{"key":"BFleu2015126_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2478\/s11658-012-0024-5","volume":"17","author":"J Savickiene","year":"2012","unstructured":"Savickiene J, Treigyte G, Borutinskaite V-V, Navakauskiene R . Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells. Cell Mol Biol Lett 2012; 17: 501\u2013525.","journal-title":"Cell Mol Biol Lett"},{"key":"BFleu2015126_CR49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/10408440591007403","volume":"35","author":"J Wiltse","year":"2005","unstructured":"Wiltse J . Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin\u2014Developmental Effects of Valproic Acid. Crit Rev Toxicol 2005; 35: 727\u2013738.","journal-title":"Crit Rev Toxicol"},{"key":"BFleu2015126_CR50","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.4161\/cc.6.24.5129","volume":"6","author":"AM Lord","year":"2007","unstructured":"Lord AM, North TE, Zon LI . Prostaglandin E2: Making more of your bone marrow. Cell Cycle 2007; 6: 3054\u20133057.","journal-title":"Cell Cycle"},{"key":"BFleu2015126_CR51","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1182\/blood-2004-04-1508","volume":"105","author":"M Iwasaki","year":"2005","unstructured":"Iwasaki M, Kuwata T, Yamazaki Y, Jenkins Na, Copeland NG, Osato M et al. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood 2005; 105: 784\u2013793.","journal-title":"Blood"},{"key":"BFleu2015126_CR52","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","volume":"136","author":"W Goessling","year":"2009","unstructured":"Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL . Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009; 136: 1136\u20131147.","journal-title":"Cell"},{"key":"BFleu2015126_CR53","doi-asserted-by":"publisher","first-page":"e1002750","DOI":"10.1371\/journal.pgen.1002750","volume":"8","author":"J Arand","year":"2012","unstructured":"Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meissner A et al. In vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases. PLoS Genet 2012; 8: e1002750.","journal-title":"PLoS Genet"},{"key":"BFleu2015126_CR54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G . Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014; 26: 577\u2013590.","journal-title":"Cancer Cell"},{"key":"BFleu2015126_CR55","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.21792","volume":"106","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian H, Issa J-PJ, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106: 1794\u20131803.","journal-title":"Cancer"},{"key":"BFleu2015126_CR56","first-page":"807","volume":"3","author":"HI Saba","year":"2007","unstructured":"Saba HI . Decitabine in the treatment of myelodysplastic syndromes. Ther Clin Risk Manag 2007; 3: 807\u2013817.","journal-title":"Ther Clin Risk Manag"},{"key":"BFleu2015126_CR57","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1038\/onc.2012.9","volume":"31","author":"Y Maslov a","year":"2012","unstructured":"Maslov a Y, Lee M, Gundry M, Gravina S, Strogonova N, Tazearslan C et al. 5-aza-2\u2019-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Oncogene 2012; 31: 5172\u20135179.","journal-title":"Oncogene"},{"key":"BFleu2015126_CR58","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1200\/JCO.2006.09.4169","volume":"25","author":"W Blum","year":"2007","unstructured":"Blum W, Klisovic RB, Hackanson B, Liu Z, Liu S, Devine H et al. Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 2007; 25: 3884\u20133891.","journal-title":"J Clin Oncol"},{"key":"BFleu2015126_CR59","doi-asserted-by":"publisher","first-page":"27586","DOI":"10.1074\/jbc.M303740200","volume":"278","author":"N Detich","year":"2003","unstructured":"Detich N, Bovenzi V, Szyf M . Valproate induces replication-independent active DNA demethylation. J Biol Chem 2003; 278: 27586\u201327592.","journal-title":"J Biol Chem"},{"key":"BFleu2015126_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/leu.2008.246","volume":"23","author":"N Misaghian","year":"2009","unstructured":"Misaghian N, Ligresti G, Steelman LS, Bertrand FE, B\u00e4secke J, Libra M et al. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 2009; 23: 25\u201342.","journal-title":"Leukemia"},{"key":"BFleu2015126_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogeden A et al. All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia. N Engl J Med 1997; 337: 1021\u20131028.","journal-title":"N Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:26:04Z","timestamp":1648743964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFleu2015126"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.126","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]},"assertion":[{"value":"21 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}